{"id":"W3120916025","doi":"10.1093/eurjpc/zwaa047","title":"EU-Wi<i>d</i>e Cross-Section<i>a</i>l Obser<i>v</i>at<i>i</i>o<i>n</i>al Study of Lipid-Modifying Therapy Use in Se<i>c</i>ondary and Pr<i>i</i>mary Care: the DA VINCI study","year":2020,"lang":"en","type":"article","venue":"European Journal of Preventive Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":767,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Netherlands Heart Institute; NIHR Imperial Biomedical Research Centre; Abbott Vascular; Esperion Therapeutics; Novo Nordisk; Teva Pharmaceutical Industries; Department of Health and Social Care; British Heart Foundation; Amryt Pharma; Allergan; AstraZeneca; Amarin Corporation; Regeneron Pharmaceuticals; Mylan; Ionis Pharmaceuticals; Valeant Pharmaceuticals International; Boston Scientific Corporation; Abbott Laboratories; National Institute for Health and Care Research; Medicines Company; Daiichi Sankyo Europe; Servier; Gilead Sciences; Celgene; Bristol-Myers Squibb; Eli Lilly and Company; Amgen; Pfizer; European Commission; Kowa Company; Sanofi","keywords":"Medicine; Section (typography); Library science; Humanities","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null}